vTv Therapeutics Inc. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$0
R&D
$18M
D&A
$16K
Operating Income
$-33M
EBITDA
$-33M
Interest Expense
$0
Interest Income
$0
Other Income/Expense
$2M
Pretax Income
$-31M
Tax Provision
$0
Net Income
$-27M
Operating Margin
-2377.6%
Net Margin
-1815.3%
Effective Tax Rate
0.0%
DTA Valuation Allowance
$50M
NOL Carryforwards
$37M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
Operating Lease Cost
$200K
Revenue YoY Variation
-100.0%
Income YoY Variation
-35.7%